News

Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.).   “As with all drugs, FDA continues to ...
Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...
The Food and Drug Administration commissioner has committed to reviewing the abortion drug mifepristone after previously ...
The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...
California and three other states have called on the FDA to ease restrictions on the abortion pill mifepristone, which they ...
The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety.
Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, ...
The FDA first approved mifepristone about a quarter of a century ago, and it's proven to be safe and effective. So why is the ...
A recent study found that 11 percent of women experience an adverse effect from mifepristone, 22 times higher than its current label indicates.
Josh Hawley, R-Mo., Makary revealed the FDA's ... "As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists ...